The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Arthur J. Matas

Department of Surgery

Division of Transplantation

420 Delaware Street SE

Mayo Mail Code 195

[email]@umn.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Surgery, Division of Transplantation, 420 Delaware Street SE, Mayo Mail Code 195. 2012
  • Department of Surgery, University of Minnesota, Minneapolis, USA. 2001 - 2011

References

  1. Ten-year outcome after rapid discontinuation of prednisone in adult primary kidney transplantation. Rizzari, M.D., Suszynski, T.M., Gillingham, K.J., Dunn, T.B., Ibrahim, H.N., Payne, W.D., Chinnakotla, S., Finger, E.B., Sutherland, D.E., Kandaswamy, R., Najarian, J.S., Pruett, T.L., Kukla, A., Spong, R., Matas, A.J. Clin. J. Am. Soc. Nephrol (2012) [Pubmed]
  2. Steroid minimization for sirolimus-treated renal transplant recipients. Matas, A.J., Granger, D., Kaufman, D.B., Sarwal, M.M., Ferguson, R.M., Woodle, E.S., Gill, J.S. Clin. Transplant (2011) [Pubmed]
  3. Histopathologic clusters differentiate subgroups within the nonspecific diagnoses of CAN or CR: preliminary data from the DeKAF study. Matas, A.J., Leduc, R., Rush, D., Cecka, J.M., Connett, J., Fieberg, A., Halloran, P., Hunsicker, L., Cosio, F., Grande, J., Mannon, R., Gourishankar, S., Gaston, R., Kasiske, B. Am. J. Transplant. (2010) [Pubmed]
  4. Minimization of steroids in kidney transplantation. Matas, A.J. Transpl. Int. (2009) [Pubmed]
  5. Kidney transplant half-life (t[1/2]) after rapid discontinuation of prednisone. Matas, A.J., Gillingham, K., Kandaswamy, R., Dunn, T.B., Payne, W.D., Sutherland, D.E., Humar, A. Transplantation (2009) [Pubmed]
  6. Steroid elimination-who, when, how? Matas, A.J. Transplant. Proc. (2008) [Pubmed]
  7. Design of a regulated system of compensation for living kidney donors. Matas, A.J. Clin. Transplant (2008) [Pubmed]
  8. Posttransplant diabetes mellitus and acute rejection: impact on kidney transplant outcome. Matas, A.J., Gillingham, K.J., Humar, A., Ibrahim, H.N., Payne, W.D., Gruessner, R.W., Dunn, T.B., Sutherland, D.E., Najarian, J.S., Kandaswamy, R. Transplantation (2008) [Pubmed]
  9. In defense of a regulated system of compensation for living donation. Matas, A.J., Hippen, B., Satel, S. Curr. Opin. Organ. Transplant (2008) [Pubmed]
  10. 2202 kidney transplant recipients with 10 years of graft function: what happens next?. Matas, A.J., Gillingham, K.J., Humar, A., Kandaswamy, R., Sutherland, D.E., Payne, W.D., Dunn, T.B., Najarian, J.S. Am. J. Transplant. (2008) [Pubmed]
  11. Resolved: in minimizing kidney transplant immunosuppression, steroids should go before calcineurin inhibitors: pro. Matas, A.J. J. Am. Soc. Nephrol. (2007) [Pubmed]
  12. The current role of calcineurin inhibitors in posttransplant immunosuppression?. Matas, A.J., Kandaswamy, R. Am. J. Transplant. (2006) [Pubmed]
  13. Why we should develop a regulated system of kidney sales: a call for action!. Matas, A.J. Clinical J. American Society Nephrology : Cjasn (2006) [Pubmed]
  14. Prednisone-free maintenance immunosuppression-a 5-year experience. Matas, A.J., Kandaswamy, R., Gillingham, K.J., McHugh, L., Ibrahim, H., Kasiske, B., Humar, A. Am. J. Transplant. (2005) [Pubmed]
  15. Long-term immunosuppression, without maintenance prednisone, after kidney transplantation. Matas, A.J., Kandaswamy, R., Humar, A., Payne, W.D., Dunn, D.L., Najarian, J.S., Gruessner, R.W., Gillingham, K.J., McHugh, L.E., Sutherland, D.E. Ann. Surg. (2004) [Pubmed]
  16. The case for living kidney sales: rationale, objections and concerns. Matas, A.J. Am. J. Transplant. (2004) [Pubmed]
  17. Morbidity and mortality after living kidney donation, 1999-2001: survey of United States transplant centers. Matas, A.J., Bartlett, S.T., Leichtman, A.B., Delmonico, F.L. Am. J. Transplant. (2003) [Pubmed]
  18. Five preventable causes of kidney graft loss in the 1990s: a single-center analysis. Matas, A.J., Humar, A., Gillingham, K.J., Payne, W.D., Gruessner, R.W., Kandaswamy, R., Dunn, D.L., Najarian, J.S., Sutherland, D.E. Kidney Int. (2002) [Pubmed]
  19. Rapid discontinuation of steroids in living donor kidney transplantation: a pilot study. Matas, A.J., Ramcharan, T., Paraskevas, S., Gillingham, K.J., Dunn, D.L., Gruessner, R.W., Humar, A., Kandaswamy, R., Najarian, J.S., Payne, W.D., Sutherland, D.E. Am. J. Transplant. (2001) [Pubmed]
 
WikiGenes - Universities